Orabloc Injection
Product Images NDC 87566-110

6 FDA label images from Aira Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Orabloc (NDC 87566-110). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aira Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Articaine HCl Structural Formula (Figure 1)

Articaine HCl Structural Formula (Figure 1)
Chemical structure of articaine hydrochloride, showing the molecular configuration and its formula C13H20N2O3S·HCl.*
FDA Label Image

Epinephrine Bitartrate Structural Formula (Figure 2)

Epinephrine Bitartrate Structural Formula (Figure 2)
Chemical structure diagram showing two molecules side by side, representing the active ingredients in Orabloc: articaine hydrochloride and epinephrine bitartrate. The image includes the molecular formulas C9H13NO3 and C4H6O6.*
FDA Label Image

Principal Display Panel – Orabloc® (articaine Hydrochloride 4% And Epinephrine 1:100,000) Injection Cartridge Label (Figure 3)

Principal Display Panel – Orabloc® (articaine Hydrochloride 4% And Epinephrine 1:100,000) Injection Cartridge Label (Figure 3)
Label for Orabloc injection containing Articaine HCl 4% and Epinephrine at a concentration of 1:100,000. The label indicates a 1.8 mL vial volume with space for lot number and expiration date. The NDC number 45146-110-02 is shown, and the product is for submucosal injection.*
FDA Label Image

Principal Display Panel – Orabloc® (articaine Hydrochloride 4% And Epinephrine 1:100,000) Injection Cartron Label (Figure 4)

Principal Display Panel – Orabloc® (articaine Hydrochloride 4% And Epinephrine 1:100,000) Injection Cartron Label (Figure 4)
Orabloc Articaine Hydrochloride 4% and Epinephrine 1:100,000 Injection in 1.8 mL cartridges. This submucosal injection is labeled for local anesthetic use in dental procedures. The package contains 50 cartridges. Distributed by Aira LLC, the box includes detailed ingredient amounts and warnings, with NDC 87566-110-50, and indicates the product is Rx only.*
FDA Label Image

Principal Display Panel – Orabloc® (articaine Hydrochloride 4% And Epinephrine 1:200,000) Injection Cartridge Label (Figure 5)

Principal Display Panel – Orabloc®  (articaine Hydrochloride 4% And Epinephrine 1:200,000) Injection Cartridge Label (Figure 5)
Label for Orabloc injection containing Articaine HCl 4% and Epinephrine 1:200,000. The dosage form is an injection with a volume of 1.8 mL. The label includes a National Drug Code (NDC# 45146-120-02) and spaces for lot number and expiration date. The labeler is Aira LLC.*
FDA Label Image

Principal Display Panel – Orabloc® (articaine Hydrochloride 4% And Epinephrine 1:200,000) Injection Cartron Label (Figure 6)

Principal Display Panel – Orabloc® (articaine Hydrochloride 4% And Epinephrine 1:200,000) Injection Cartron Label (Figure 6)
Orabloc injection label containing Articaine Hydrochloride 4% and Epinephrine 1:200,000 for submucosal route. The package is for 50 cartridges, each cartridge 1.8 mL, distributed by Aira LLC. The label includes active ingredient amounts, usage direction for dental submucosal injection, and storage instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.